RS56044B1 - Primena kombinovanih preparata koji sadrže antimikotike - Google Patents

Primena kombinovanih preparata koji sadrže antimikotike

Info

Publication number
RS56044B1
RS56044B1 RS20170559A RSP20170559A RS56044B1 RS 56044 B1 RS56044 B1 RS 56044B1 RS 20170559 A RS20170559 A RS 20170559A RS P20170559 A RSP20170559 A RS P20170559A RS 56044 B1 RS56044 B1 RS 56044B1
Authority
RS
Serbia
Prior art keywords
therapy
candidiasis
combination
disease
vaginal
Prior art date
Application number
RS20170559A
Other languages
English (en)
Serbian (sr)
Inventor
Christian Noe
Marion Noe-Letschnig
Original Assignee
Christian Noe
Marion Noe-Letschnig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Noe, Marion Noe-Letschnig filed Critical Christian Noe
Publication of RS56044B1 publication Critical patent/RS56044B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
RS20170559A 2006-05-12 2007-05-10 Primena kombinovanih preparata koji sadrže antimikotike RS56044B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT8262006 2006-05-12
EP07718439.8A EP2018164B1 (de) 2006-05-12 2007-05-10 Verwendung von kombinationspräparaten, umfassend antimykotika
PCT/AT2007/000227 WO2007131253A2 (de) 2006-05-12 2007-05-10 Verwendung von kombinationspräparaten, umfassend antimykotika

Publications (1)

Publication Number Publication Date
RS56044B1 true RS56044B1 (sr) 2017-09-29

Family

ID=37903545

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20170559A RS56044B1 (sr) 2006-05-12 2007-05-10 Primena kombinovanih preparata koji sadrže antimikotike

Country Status (19)

Country Link
US (2) US8552042B2 (https=)
EP (2) EP2018164B1 (https=)
JP (1) JP2009536926A (https=)
CN (1) CN101484162A (https=)
AU (1) AU2007250502B2 (https=)
CA (1) CA2651726C (https=)
CY (1) CY1119094T1 (https=)
DK (1) DK2018164T3 (https=)
ES (1) ES2627268T3 (https=)
HR (1) HRP20170793T1 (https=)
HU (1) HUE033499T2 (https=)
LT (1) LT2018164T (https=)
NO (2) NO342103B1 (https=)
PL (1) PL2018164T3 (https=)
PT (1) PT2018164T (https=)
RS (1) RS56044B1 (https=)
RU (1) RU2008148977A (https=)
SI (1) SI2018164T1 (https=)
WO (1) WO2007131253A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23311A (sl) * 2010-03-19 2011-09-30 Kemijski inštitut Farmacevtska kombinacija acetilsalicilne kisline in protiglivne substance za uničevanje ali inhibicijo rasti in replikacije gliv
CN102210649A (zh) * 2010-04-09 2011-10-12 上海医药科技发展有限公司 一种两性霉素b乳膏及其制备方法
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
CN103044408A (zh) * 2013-01-21 2013-04-17 万礼 在治疗恶性肿瘤时应用的伊曲康唑或其盐及其组合物
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
BR112017014295B1 (pt) 2015-01-13 2023-04-25 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A Composição farmacêutica.
CN104920360B (zh) * 2015-06-18 2017-04-12 青岛农业大学 丁苯羟酸在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的用途
EP3482744A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
BR112020009454A2 (pt) 2017-11-14 2020-10-13 Profem Gmbh emulsões para o tratamento de infecções da mucosa
EP3482743A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur behandlung von scheideninfektionen
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
US20250302821A1 (en) * 2022-05-12 2025-10-02 St. Jude Children's Research Hospital, Inc. Synergistic antifungal composition and method
WO2024187210A1 (de) 2023-03-15 2024-09-19 Profem Gmbh Kombinationsarzneimittel zur behandlung und reduktion der rückfallraten vaginaler mykosen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6471823A (en) * 1987-09-12 1989-03-16 Rohto Pharma Sustained remedy for vaginal candidiasis
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
EP0735861A1 (en) * 1993-12-23 1996-10-09 The Procter & Gamble Company Tissue moisturizing and antimicrobial compositions
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
WO2000048633A1 (en) 1999-02-19 2000-08-24 Ligocyte Pharmaceuticals, Inc. Antibodies against hydrophobic proteins that are protective against candidiasis
EP1191939B1 (en) * 1999-03-24 2007-10-17 Zengen, Inc. Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040142910A1 (en) * 2002-10-21 2004-07-22 Aegis Biosciences Llc Sulfonated styrene copolymers for medical uses
WO2004060283A2 (en) * 2002-12-16 2004-07-22 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
JPWO2005000287A1 (ja) 2003-06-25 2006-10-05 久光製薬株式会社 水虫治療用外用剤
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
TWI290051B (en) 2004-05-28 2007-11-21 Schering Corp Particulate-stabilized injectable pharmaceutical compositions of Posaconazole

Also Published As

Publication number Publication date
EP3192507B1 (de) 2020-07-08
CA2651726A1 (en) 2007-11-22
HUE033499T2 (en) 2017-12-28
SI2018164T1 (sl) 2017-07-31
US20090208558A1 (en) 2009-08-20
JP2009536926A (ja) 2009-10-22
WO2007131253A2 (de) 2007-11-22
RU2008148977A (ru) 2010-06-20
AU2007250502B2 (en) 2013-11-28
AU2007250502A1 (en) 2007-11-22
DK2018164T3 (en) 2017-06-12
US8815925B2 (en) 2014-08-26
NO20085181L (no) 2009-02-10
PL2018164T3 (pl) 2017-08-31
CN101484162A (zh) 2009-07-15
CY1119094T1 (el) 2018-01-10
LT2018164T (lt) 2017-07-10
EP3192507A1 (de) 2017-07-19
ES2627268T3 (es) 2017-07-27
EP2018164A2 (de) 2009-01-28
NO20180083A1 (no) 2009-02-10
PT2018164T (pt) 2017-06-12
NO342103B1 (no) 2018-03-26
HRP20170793T1 (hr) 2017-10-06
NO345064B1 (no) 2020-09-14
EP2018164B1 (de) 2017-03-01
CA2651726C (en) 2015-12-15
WO2007131253A3 (de) 2008-11-27
US8552042B2 (en) 2013-10-08
US20140030312A1 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
RS56044B1 (sr) Primena kombinovanih preparata koji sadrže antimikotike
Perezous et al. Colonization of Candida species in denture wearers with emphasis on HIV infection: a literature review
AU2010212634B2 (en) Combination of avermectins or mylbemycins with adrenergic receptors for treating or preventing skin diseases
CN102481290A (zh) 用于治疗红斑痤疮或红脸相关皮肤病的含黄连素或其类似物的组合物
JP2011529038A5 (https=)
JP2018502128A (ja) 真菌感染を阻害するための組成物および方法
JP7378409B2 (ja) 皮膚および粘膜感染症の局所治療用エマルション
US20180303874A1 (en) Compositions and Methods for the Prevention of Microbial Infections
KR101100713B1 (ko) 아스코르브산을 포함하는 진균성 중복감염들 및 진균성재발들의 치료용 약학적 조성물들
TYu et al. Vulvovaginal candidiasis: modern look at the problem
Botter Further experiences with miconazole nitrate, a broad‐spectrum antimycotic with antibacterial activity
CN104244942A (zh) 两性表面活性剂在预防和治疗阴道感染中的致病性阴道生物被膜中的应用
TWI329650B (en) Medicament for the treatment or prevention of acne
AU2016203125B2 (en) Use of combination preparations, comprising antimycotics
Cappelli et al. Evidence on a New Thymol and Zinc-Based Cleanser for Feminine Hygiene in a Double-Blind Controlled Randomized Study
RU2837356C1 (ru) Жидкая фармацевтическая композиция на основе комбинации бензидамина, октенидина и феноксиэтанола для профилактики и лечения инфекционных и воспалительных заболеваний лор-органов
AU2013254945A1 (en) Use of combination preparations, comprising antimycotics
OLTEAN MANAGEMENT OF MUCOCUTANEOUS CANDIDIASIS
Kronemyer Ibrexafungerp vs fluconazole for VVC
RU2454233C2 (ru) Фармацевтическая композиция для местного применения в гинекологии
TW201124138A (en) Imidazole-4-carboxylic acid for use in treating a disease related to extracellular reactive oxygen species